ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Schizophrenia
Schizoaffective Disorder
2 Additional conditions recognized in this trial
Psychotic Disorders
Recurrence
3 More general conditions related to this trial
Disease Attributes
Mental Disorders
Pathologic Processes
Schizophrenia and Disorders with Psychotic Features
4 Interventions listed in this trial
Risperidone microspheres
Risperidone
Olanzapine
Quetiapine
Ziprasidone
Aripiprazole
Paliperidone
5 Additional drug interventions recognized in this trial
9-hydroxy-risperidone
6 More general drug interventions related to this trial
Antiemetics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Serotonin Uptake Inhibitors
Therapeutic Uses
Tranquilizing Agents
7 Sponsors listed in this trial
National Institute of Mental Health (NIMH)




Links to all studies - primarily for crawlers